Clinical Trial Update: Treating Nightmares in Posttraumatic Stress Disorder With Dronabinol [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dronabinol for nightmares in posttraumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: COMPLETED